EH
Eddie Hickman Guggenheim Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
14
Avg Return
Past Year
Past Year
173%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
92.9%
Neutral
7.1%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $48 |
551%
upside
| 2 | +4.4% |
0
%
| 3 Dec ‘25 1 month ago |
|
|
|
Buy
Maintained
| $5 |
41%
downside
| 3 | +731% |
0
%
| 18 Nov ‘25 1 month ago |
|
|
|
Buy
Maintained
| $87 |
11%
upside
| 5 | +10% |
0
%
| 5 Nov ‘25 2 months ago |
|
|
|
Neutral
Downgraded
| – | – | 2 | -50% |
0
%
| 29 Aug ‘25 4 months ago |
|
|
|
Buy
Maintained
| $22 |
155%
upside
| 1 | +9% |
0
%
| 13 Mar ‘25 10 months ago |
|
|
|
Buy
Initiated
| $32 |
106%
upside
| 1 | +37% |
0
%
| 13 Mar ‘25 10 months ago |
|